An innovative use of HSV-1 vectors lays the foundation for a novel genetic screen for modulators of ligand-gated ion channels.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Srinivasan, R. et al. Nat. Methods 4, 733–739 (2007).
Szallasi, A., Cortright, D.N., Blum, C.A. & Eid, S.R. Nat. Rev. Drug Discov. 6, 357–372 (2007).
Okuse, K. et al. Nature 417, 653–656 (2002).
Jegla, T. & Salkhoff, L. J. Neurosci. 17, 32–44 (1997).
Wang, Y. et al. Am. J. Physiol. Cell Physiol. 278, C619–C626 (2000).
Fink, D.J., DeLuca, N.A., Goins, W.F. & Glorioso, J.C. et al. Annu. Rev. Neurosci. 19, 265–287 (1996).
Burton, E.A. et al. Stem Cells 19, 358–377 (2001).
Yeomans, D.C. et al. Hum. Gene Ther. 16, 271–277 (2005).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
All of the authors work for the Neurogen Corporation, which is in the business of identifying novel drug therapies, some of which may target ion channels such as Trpv1.
Rights and permissions
About this article
Cite this article
Cortright, D., Buck, M. & Krause, J. Hunting for ion channel modulators with herpes simplex virus. Nat Methods 4, 692–693 (2007). https://doi.org/10.1038/nmeth0907-692
Issue Date:
DOI: https://doi.org/10.1038/nmeth0907-692
This article is cited by
-
TRPV4 channel is involved in HSV-2 infection in human vaginal epithelial cells through triggering Ca2+ oscillation
Acta Pharmacologica Sinica (2023)